Syncope Clinical Trial
Official title:
The Effect of Water Carbonation on Orthostatic Tolerance
The primary purpose of this investigation is to determine whether water carbonation can improve orthostatic tolerance in healthy control volunteers. Orthostatic tolerance refers to the ability to maintain an adequate blood pressure when standing. In some individuals blood pressure can fall when standing, predisposing to dizzy spells or fainting episodes. Drinking water can boost blood pressure and making fainting episodes less likely. However, it is not clear whether the carbonation of the water has any further impact on the blood pressure response. This is important because it may be that carbonated water expands the stomach (gastric distension), provoking an increase in sympathetic activity. The increase in sympathetic nervous system activity boosts blood pressure. Resolving this question would have important implications for patients with syncope. This study will test whether carbonated water will have any further impact on blood pressure than the already known effect of non-carbonated water.
The primary purpose of this investigation is to determine whether water carbonation can improve orthostatic tolerance in healthy control volunteers. Orthostatic tolerance refers to the ability to maintain an adequate blood pressure when standing [1]. In some individuals blood pressure can fall when standing, predisposing to dizzy spells or fainting episodes [1]. Drinking water can boost blood pressure and making fainting episodes less likely [2-8]. However, it is not clear whether the carbonation of the water has any further impact on the blood pressure response [9,10]. This is important because it may be that carbonated water expands the stomach (gastric distension), provoking an increase in sympathetic activity. The increase in sympathetic nervous system activity boosts blood pressure. Resolving this question would have important implications for patients with syncope. This study will test whether carbonated water will have any further impact on blood pressure than the already known effect of non-carbonated water. Volunteers (n=25) will be asked to undergo a "tilt test" to assess cardiovascular reflex control and orthostatic tolerance (measured as time to presyncope, or near fainting, in minutes). It has been previously shown that this technique to be reproducible, reliable, and to have high sensitivity and specificity for differentiating persons with differing orthostatic tolerance, or for examining the effects of interventions aimed at improving orthostatic tolerance [4,6,11-18]. Volunteers will undergo this test on three separate days. On each day participants will be asked to drink a glass of water: either a 50ml drink of room temperature water (control condition), a 500ml drink of flat (non-carbonated) room temperature water, or a 500ml drink of carbonated room temperature water. The study will be conducted in a randomised, single-blind fashion. The investigator responsible for terminating the test will be blinded as to the water condition on each test day, rendering the study single blind. It will not be possible to blind participants as to the carbonation of the water, however, participants will not be informed as to the hypothesised impact of the water conditions. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06038708 -
Head-up Tilt Test in Patients With Reflex Syncope and Asystolic Response Who Received a Dual-chamber Pacemaker With the Closed Loop Stimulation (CLS) and Participated in the BIOSync Trial
|
||
Completed |
NCT00069693 -
Evaluation of Chronic Orthostatic Intolerance
|
N/A | |
Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
Completed |
NCT02565238 -
BIO.MASTER.BioMonitor 2 Study
|
N/A | |
Active, not recruiting |
NCT01965899 -
Usability Study to Assess the Reveal LINQ Insertable Cardiac Monitor System
|
N/A | |
Completed |
NCT00746564 -
Study of New Implantable Loop Recorder
|
N/A | |
Completed |
NCT00359203 -
ISSUE3: International Study on Syncope of Uncertain Etiology 3
|
Phase 4 | |
Recruiting |
NCT04972071 -
SW-RCT Implementation of Canadian Syncope Risk Score Based Practice Recommendations
|
N/A | |
Completed |
NCT04198220 -
BIO|STREAM.ICM Obesity
|
||
Recruiting |
NCT04533425 -
Practical Approaches to Care in Emergency Syncope
|
||
Completed |
NCT05571254 -
The Management of Transient Loss of Consciousness and Suspected Syncope in European Emergency Departments
|
||
Not yet recruiting |
NCT05957315 -
Mobile Cardiac Outpatient Telemetry for Unexplained Syncope
|
N/A | |
Recruiting |
NCT04615065 -
Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
|
||
Completed |
NCT05729724 -
Effect of Pharmacological Interventions on Systolic Blood Pressure Drops (SynABPM 2 Proof-of-concept)
|
||
Completed |
NCT05782712 -
Rapid Measurement of Adenosine in Syncope Patients
|
||
Completed |
NCT03786640 -
Abbott Brady 3T MRI PMCF
|
||
Recruiting |
NCT03803969 -
ConfirmRxTM: Posture and Activity
|
N/A | |
Recruiting |
NCT05575934 -
Management of Transitory Loss of Consciousness and Syncopes in the Emergency Department
|
||
Recruiting |
NCT04075084 -
Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
|
||
Completed |
NCT02786940 -
Remote Cardiac Monitoring of Higher-Risk Emergency Department Syncope Patients After Discharge - A Pilot Study
|
N/A |